Cargando…

RNA sequencing analysis reveals increased expression of interferon signaling genes and dysregulation of bone metabolism affecting pathways in the whole blood of patients with osteogenesis imperfecta

BACKGROUND: Osteogenesis imperfecta (OI) is a rare genetic disorder in which the patients suffer from numerous fractures, skeletal deformities and bluish sclera. The disorder ranges from a mild form to severe and lethal cases. The main objective of this pilot study was to compare the blood transcrip...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhytnik, Lidiia, Maasalu, Katre, Reimann, Ene, Märtson, Aare, Kõks, Sulev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684725/
https://www.ncbi.nlm.nih.gov/pubmed/33228694
http://dx.doi.org/10.1186/s12920-020-00825-7
_version_ 1783613055606718464
author Zhytnik, Lidiia
Maasalu, Katre
Reimann, Ene
Märtson, Aare
Kõks, Sulev
author_facet Zhytnik, Lidiia
Maasalu, Katre
Reimann, Ene
Märtson, Aare
Kõks, Sulev
author_sort Zhytnik, Lidiia
collection PubMed
description BACKGROUND: Osteogenesis imperfecta (OI) is a rare genetic disorder in which the patients suffer from numerous fractures, skeletal deformities and bluish sclera. The disorder ranges from a mild form to severe and lethal cases. The main objective of this pilot study was to compare the blood transcriptional landscape of OI patients with COL1A1 pathogenic variants and their healthy relatives, in order to find out different gene expression and dysregulated molecular pathways in OI. METHODS: We performed RNA sequencing analysis of whole blood in seven individuals affected with different OI severity and their five unaffected relatives from the three families. The data was analyzed using edgeR package of R Bioconductor. Functional profiling and pathway analysis of the identified differently expressed genes was performed with g:GOSt and MinePath web-based tools. RESULTS: We identified 114 differently expressed genes. The expression of 79 genes was up-regulated, while 35 genes were down-regulated. The functional analysis identified a presence of dysregulated interferon signaling pathways (IFI27, IFITM3, RSAD12, GBP7). Additionally, the expressions of the genes related to extracellular matrix organization, Wnt signaling, vitamin D metabolism and MAPK-ERK 1/2 pathways were also altered. CONCLUSIONS: The current pilot study successfully captured the differential expression of inflammation and bone metabolism pathways in OI patients. This work can contribute to future research of transcriptional bloodomics in OI. Transcriptional bloodomics has a strong potential to become a major contributor to the understanding of OI pathological mechanisms, the discovery of phenotype modifying factors, and the identification of new therapeutic targets. However, further studies in bigger cohorts of OI patients are needed to confirm the findings of the current work.
format Online
Article
Text
id pubmed-7684725
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76847252020-11-24 RNA sequencing analysis reveals increased expression of interferon signaling genes and dysregulation of bone metabolism affecting pathways in the whole blood of patients with osteogenesis imperfecta Zhytnik, Lidiia Maasalu, Katre Reimann, Ene Märtson, Aare Kõks, Sulev BMC Med Genomics Research Article BACKGROUND: Osteogenesis imperfecta (OI) is a rare genetic disorder in which the patients suffer from numerous fractures, skeletal deformities and bluish sclera. The disorder ranges from a mild form to severe and lethal cases. The main objective of this pilot study was to compare the blood transcriptional landscape of OI patients with COL1A1 pathogenic variants and their healthy relatives, in order to find out different gene expression and dysregulated molecular pathways in OI. METHODS: We performed RNA sequencing analysis of whole blood in seven individuals affected with different OI severity and their five unaffected relatives from the three families. The data was analyzed using edgeR package of R Bioconductor. Functional profiling and pathway analysis of the identified differently expressed genes was performed with g:GOSt and MinePath web-based tools. RESULTS: We identified 114 differently expressed genes. The expression of 79 genes was up-regulated, while 35 genes were down-regulated. The functional analysis identified a presence of dysregulated interferon signaling pathways (IFI27, IFITM3, RSAD12, GBP7). Additionally, the expressions of the genes related to extracellular matrix organization, Wnt signaling, vitamin D metabolism and MAPK-ERK 1/2 pathways were also altered. CONCLUSIONS: The current pilot study successfully captured the differential expression of inflammation and bone metabolism pathways in OI patients. This work can contribute to future research of transcriptional bloodomics in OI. Transcriptional bloodomics has a strong potential to become a major contributor to the understanding of OI pathological mechanisms, the discovery of phenotype modifying factors, and the identification of new therapeutic targets. However, further studies in bigger cohorts of OI patients are needed to confirm the findings of the current work. BioMed Central 2020-11-23 /pmc/articles/PMC7684725/ /pubmed/33228694 http://dx.doi.org/10.1186/s12920-020-00825-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Zhytnik, Lidiia
Maasalu, Katre
Reimann, Ene
Märtson, Aare
Kõks, Sulev
RNA sequencing analysis reveals increased expression of interferon signaling genes and dysregulation of bone metabolism affecting pathways in the whole blood of patients with osteogenesis imperfecta
title RNA sequencing analysis reveals increased expression of interferon signaling genes and dysregulation of bone metabolism affecting pathways in the whole blood of patients with osteogenesis imperfecta
title_full RNA sequencing analysis reveals increased expression of interferon signaling genes and dysregulation of bone metabolism affecting pathways in the whole blood of patients with osteogenesis imperfecta
title_fullStr RNA sequencing analysis reveals increased expression of interferon signaling genes and dysregulation of bone metabolism affecting pathways in the whole blood of patients with osteogenesis imperfecta
title_full_unstemmed RNA sequencing analysis reveals increased expression of interferon signaling genes and dysregulation of bone metabolism affecting pathways in the whole blood of patients with osteogenesis imperfecta
title_short RNA sequencing analysis reveals increased expression of interferon signaling genes and dysregulation of bone metabolism affecting pathways in the whole blood of patients with osteogenesis imperfecta
title_sort rna sequencing analysis reveals increased expression of interferon signaling genes and dysregulation of bone metabolism affecting pathways in the whole blood of patients with osteogenesis imperfecta
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684725/
https://www.ncbi.nlm.nih.gov/pubmed/33228694
http://dx.doi.org/10.1186/s12920-020-00825-7
work_keys_str_mv AT zhytniklidiia rnasequencinganalysisrevealsincreasedexpressionofinterferonsignalinggenesanddysregulationofbonemetabolismaffectingpathwaysinthewholebloodofpatientswithosteogenesisimperfecta
AT maasalukatre rnasequencinganalysisrevealsincreasedexpressionofinterferonsignalinggenesanddysregulationofbonemetabolismaffectingpathwaysinthewholebloodofpatientswithosteogenesisimperfecta
AT reimannene rnasequencinganalysisrevealsincreasedexpressionofinterferonsignalinggenesanddysregulationofbonemetabolismaffectingpathwaysinthewholebloodofpatientswithosteogenesisimperfecta
AT martsonaare rnasequencinganalysisrevealsincreasedexpressionofinterferonsignalinggenesanddysregulationofbonemetabolismaffectingpathwaysinthewholebloodofpatientswithosteogenesisimperfecta
AT kokssulev rnasequencinganalysisrevealsincreasedexpressionofinterferonsignalinggenesanddysregulationofbonemetabolismaffectingpathwaysinthewholebloodofpatientswithosteogenesisimperfecta